Context Therapeutics Inc (CNTX)
2.25
-0.02
(-0.88%)
USD |
NASDAQ |
Nov 04, 13:14
Context Therapeutics Price to Book Value: 1.669 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 01, 2024 | 1.684 |
October 31, 2024 | 1.617 |
October 30, 2024 | 1.610 |
October 29, 2024 | 1.662 |
October 28, 2024 | 1.706 |
October 25, 2024 | 1.736 |
October 24, 2024 | 1.743 |
October 23, 2024 | 1.654 |
October 22, 2024 | 1.484 |
October 21, 2024 | 1.528 |
October 18, 2024 | 1.513 |
October 17, 2024 | 1.491 |
October 16, 2024 | 1.521 |
October 15, 2024 | 1.446 |
October 14, 2024 | 1.476 |
October 11, 2024 | 1.454 |
October 10, 2024 | 1.268 |
October 09, 2024 | 1.365 |
October 08, 2024 | 1.380 |
October 07, 2024 | 1.358 |
October 04, 2024 | 1.424 |
October 03, 2024 | 1.469 |
October 02, 2024 | 1.402 |
October 01, 2024 | 1.380 |
September 30, 2024 | 1.454 |
Date | Value |
---|---|
September 27, 2024 | 1.380 |
September 26, 2024 | 1.372 |
September 25, 2024 | 1.432 |
September 24, 2024 | 1.454 |
September 23, 2024 | 1.543 |
September 20, 2024 | 1.676 |
September 19, 2024 | 1.654 |
September 18, 2024 | 1.454 |
September 17, 2024 | 1.543 |
September 16, 2024 | 1.543 |
September 13, 2024 | 1.550 |
September 12, 2024 | 1.595 |
September 11, 2024 | 1.587 |
September 10, 2024 | 1.58 |
September 09, 2024 | 1.587 |
September 06, 2024 | 1.721 |
September 05, 2024 | 1.691 |
September 04, 2024 | 1.802 |
September 03, 2024 | 1.817 |
August 30, 2024 | 1.825 |
August 29, 2024 | 1.817 |
August 28, 2024 | 1.825 |
August 27, 2024 | 1.854 |
August 26, 2024 | 1.854 |
August 23, 2024 | 1.840 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.256
Minimum
Dec 28 2022
19.45
Maximum
Jun 25 2024
1.776
Average
0.7399
Median
Jul 12 2022
Price to Book Value Benchmarks
Collegium Pharmaceutical Inc | 4.977 |
NovaBay Pharmaceuticals Inc | -- |
Palatin Technologies Inc | -- |
iBio Inc | 1.110 |
Theriva Biologics Inc | 0.0756 |
Price to Book Value Related Metrics
Price | 2.25 |
Earnings Yield | -47.11% |
Market Cap | 168.75M |